Faster, Smarter Drug Discovery: What Generate Biomedicines Means for Healthcare Innovation
Generate Biomedicines’ $400M IPO signals AI-designed medicines are going mainstream—what it means for trials, regula
Notice: Test mode is enabled. While in test mode no live donations are processed.
Generate Biomedicines’ $400M IPO signals AI-designed medicines are going mainstream—what it means for trials, regula
An AIIMS study shows a cough-analyzing smartphone app could flag COPD risk fast—supporting better triage in primary ca
AI is helping drugmakers speed up clinical trials and regulatory submissions—cutting delays and getting treatments to